Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

DNTH Dianthus Therapeutics PE ratio, current and historical analysis

The current P/E ratio of DNTH cannot be calculated, as the latest EPS of -$2.89 is negative. The most recent PE ratio recorded for Dianthus Therapeutics was 3.82 in September 2024.

DNTH PE ratio history

How has DNTH's PE ratio performed in the past
Today
N/A
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A

Dianthus Therapeutics PE ratio by year

Year PE ratio PE change Price EPS
2024 N/A N/A $21.8 -$2.55
2023 N/A N/A $10.4 -$8.45
2022 N/A N/A $6.32 -$32.57
2021 N/A N/A $70.88 -$20.64
2020 N/A N/A $125.44 -$27.36
2019 N/A N/A $242.56 -$33.12
2018 N/A N/A $91.2 -$50.08
2017 N/A N/A N/A -$305.92
2016 N/A N/A N/A -$1,042.4

Dianthus Therapeutics PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Mar 2025 N/A N/A $18.14 -$2.89
Dec 2024 N/A N/A $21.8 -$2.55
Sep 2024 3.82 -39.17% $27.38 $7.16
Jun 2024 6.28 N/A $25.88 $4.12
Mar 2024 N/A N/A $30 -$8.1
Dec 2023 N/A N/A $10.4 -$8.45
Sep 2023 N/A N/A $13.67 -$36.18
Jun 2023 N/A N/A $12.13 -$41.3
Mar 2023 N/A N/A $12.72 -$33.21
Dec 2022 N/A N/A $6.32 -$32.57
Sep 2022 N/A N/A $22.56 -$24.9
Jun 2022 N/A N/A $19.2 -$20.8
Mar 2022 N/A N/A $46.4 -$21.28
Dec 2021 N/A N/A $70.88 -$20.64
Sep 2021 N/A N/A $116.48 -$21.6

DNTH Price vs fair value

How does DNTH's price compare to its estimated fair value based on its growth

DNTH average PE ratio chart

What is the average PE ratio of DNTH for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

DNTH PE vs peers

What is DNTH's PE ratio compared to its peers
Stock name PE ratio Market cap
OLMA Olema Pharmaceuticals Inc N/A $288.74M
OMER Omeros Corp N/A $195.7M
VIVS VivoSim Labs Inc. N/A $2.66M
ORIC Oric Pharmaceuticals Inc N/A $645.48M
ORMP Oramed Pharmaceuticals Inc N/A $93.14M
DNTH Dianthus Therapeutics Inc N/A $577.59M

Frequently asked questions

What is Dianthus Therapeutics's PE ratio?

The current price to earnings ratio of DNTH cannot be determined, as its EPS of -$2.89 is negative.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.